Augmentation of NRF2 signaling by SFN treatment is hence anticipated to rescue cancer cells from oxidative DNA damage, which in turn promotes tumor growth and survival in DEN-induced hepatocarcinogenesis. This evidence concerns the gene NFE2L2 and cancer.